The India, Pakistan & Cambodia Human Immunodeficiency Virus (HIV) Treatment Market is expected to grow at a CAGR during the forecasting period (2022-2029).
Human immunodeficiency virus (HIV) is a chronic and life-threatening disease, which can be transferred from one person to another through blood-to-blood and sexual contact.
HIV attacks immune cells known as CD-4 cells, making the body susceptible to infections and other diseases.
The rising prevalence of HIV disease has positively influenced the demand for HIV drugs. HIV drugs help to prevent the multiplication of HIV, thereby reducing the risk of its transmission.
The recent COVID-19 outbreak has impacted the growth of the HIV treatment market. HIV drugs are repurposed to treat COVID-19 infections. Several countries are evaluating and using antiretroviral drugs (for instance lopinavir boosted with ritonavir (LPV/r)), for treating coronavirus infection.
Some of the major players in the HIV treatment market are Merck & Co., Inc., Bristol-Myers Squibb Company, Janssen (Johnson & Johnson), F. Hoffmann-La Roche Ltd, Boehringer Ingelheim, GlaxoSmithKline plc, and Mylan Pharmaceutical
Get your free sample proposal with a single click!